Advisornet Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.5K Buy
106
+103
+3,433% +$22.6K ﹤0.01% 1316
2026
Q1
$567 Hold
3
– – ﹤0.01% 2082
2025
Q4
$510 Hold
3
– – ﹤0.01% 2087
2025
Q3
$395 Hold
3
– – ﹤0.01% 2096
2025
Q2
$318 Buy
3
+1
+50% +$109 ﹤0.01% 2110
2025
Q1
$248 Buy
+2
New +$261 ﹤0.01% 2056
2024
Q2
– Sell
-2
Closed -$241 – 2135
2024
Q1
$241 Sell
2
-5
-71% -$612 ﹤0.01% 1956
2023
Q4
$861 Sell
7
-6
-46% -$749 ﹤0.01% 1931
2023
Q3
$1.68K Buy
13
+2
+18% +$266 ﹤0.01% 1681
2023
Q2
$1.36K Buy
11
+3
+38% +$404 ﹤0.01% 1800
2023
Q1
$1.17K Sell
8
-4
-33% -$592 ﹤0.01% 1836
2022
Q4
$1.91K Buy
12
+11
+1,100% +$1.61K ﹤0.01% 1679
2022
Q3
$0 Buy
+1
New +$152 ﹤0.01% 1951
2022
Q1
– Sell
-768
Closed -$98K – 2089
2021
Q4
$98K Buy
768
+23
+3% +$3.02K 0.01% 820
2021
Q3
$97K Sell
745
-15
-2% -$2.27K 0.01% 799
2021
Q2
$135K Buy
760
+27
+4% +$4.68K 0.01% 699
2021
Q1
$120K Sell
733
-144
-16% -$23.7K 0.01% 701
2020
Q4
$145K Sell
877
-50
-5% -$7.45K 0.01% 585
2020
Q3
$132K Hold
927
– – 0.01% 599
2020
Q2
$102K Hold
927
– – 0.01% 661
2020
Q1
$92K Sell
927
-91
-9% -$11.8K 0.01% 639
2019
Q4
$152K Buy
1,018
+730
+253% +$99.3K 0.01% 570
2019
Q3
$37K Buy
+288
New +$38.6K ﹤0.01% 1009

Other funds holding JAZZ

Advisornet Financial's JAZZ Position: Q2 2026 in Review

Advisornet Financial increased its Jazz Pharmaceuticals (JAZZ) stake by 3,433% in Q2 2026, buying an estimated $22.6K and bringing the position to 106 shares worth $25.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1316.

Advisornet Financial first reported a position in JAZZ in Q3 2019 and has held it in 23 quarters since. The position peaked at $152K in Q4 2019. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Advisornet Financial held 106 shares of Jazz Pharmaceuticals worth $25.5K as of Q2 2026.
  • Advisornet Financial bought 103 Jazz Pharmaceuticals shares in Q2 2026, an estimated $22.6K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #1316 holding.
  • Advisornet Financial first reported a position in Jazz Pharmaceuticals in Q3 2019 and has held it in 23 quarters since.
  • Advisornet Financial's Jazz Pharmaceuticals position peaked at $152K in Q4 2019.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.